Literature DB >> 3037017

Virus-specific IgM and IgG antibody production by B cells during herpes simplex virus type 2-induced immunosuppression as analysed by an immunospot assay.

S Nick, B Metzger, S Muller, D Falke.   

Abstract

The mechanism of herpes simplex virus (HSV)-2-induced immunosuppression was analysed by determination of the number of IgM and IgG antibody-secreting B cells in female BALB/c mice using an immunospot assay. Primary HSV-1 or -2 as well as homologous or heterologous booster infections at different times were performed. In accordance with earlier results on humoral antibody generation, in contrast to HSV-1, HSV-2 induced only very low numbers of antibody-producing B cells in dose-response experiments. They appeared late after infection compared to HSV-1. Despite a homologous humoral booster reaction against HSV-1 at day 8 no IgM- or IgG-secreting cells in the spleen could be detected. This non-reactivity of the spleen had vanished 10 days later, when secondary reactions of B cells could be observed. Secondary infections with a high homologous dose of HSV-2 after a low primary dose produced only a low booster response of IgG-secreting B cells. Suppression of humoral antibody production induced by HSV-2 (high dose) waned after more than 50 days, indicating that the HSV-2-induced suppression did not impair antigen presentation or memory cell generation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037017     DOI: 10.1099/0022-1317-68-7-1951

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Suppression of humoral antibody formation against sheep red blood cells by infections with HSV-2 and the influence of mouse cytomegalovirus. Brief report.

Authors:  S Nick; B Metzger; S Jonsić; D Falke
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  A vaccinia virus--herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice.

Authors:  M Fleck; J Podlech; K Weise; D Falke
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

3.  Suppression of humoral immune response against herpes simplex virus induced by defective strains, ts- and TK- mutants.

Authors:  B Metzger; J Podlech; S Müller; D Falke
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.